Tone mix
Week by week 52 weeks
Share of Amgen Inc's 800 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of May 11, 2026 · tone +75Amgen Touts Repatha Growth, MariTide Potential and 2026 'Springboard' at Conference+53
- Week of Jun 29, 2026 · tone -37Amgen Inc. faces recall of Corlanor and Sensipar medications-36
- Week of Oct 26, 2026 · tone +48Amgen drug combined with immunotherapy extends survival in lung cancer trial+35
- Week of Apr 13, 2026 · tone +62Amgen (NASDAQ:AMGN) Price Target Raised to $351.00+34
- Week of May 18, 2026 · tone -19Amgen's rare disease drug linked to deaths, liver injuries in Japan-32
- Week of Feb 23, 2026 · tone -5Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate-28
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Amgen Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 16 | +51 |
| Last 30 sessions | 70 | +32 |
| Last 90 sessions | 235 | +15 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
3 headlines, average tone +66: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.dailypolitical.com · 1 outletAmgen (NASDAQ:AMGN) Price Target Raised to $435.00Positive
- www.rttnews.com · 1 outletAmgen's Real-World Data Shows Repatha Outperforms Ezetimibe For Heart DiseasePositive
- www.fool.com · 1 outletAmgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?Neutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amgen (NASDAQ:AMGN) Price Target Raised to $435.00 | www.dailypolitical.com | 1 | Positive |
| Amgen's Real-World Data Shows Repatha Outperforms Ezetimibe For Heart Disease | www.rttnews.com | 1 | Positive |
| Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027? | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
6 headlines, average tone +53: 4 positive, 1 neutral and 1 negative. Showing all 6.
- www.themarketsdaily.com · 1 outletAmgen (NASDAQ:AMGN) Reaches New 1-Year High on Strong EarningsPositive
- www.themarketsdaily.com · 1 outletAmgen (NASDAQ:AMGN) Stock Gets Price Target Increase from The Goldman Sachs GroupPositive
- www.pacbiztimes.com · 1 outletAmgen stock up after Q3 earnings beat | Pacific Coast Business TimesPositive
- www.themarketsdaily.com · 1 outletAmgen (NASDAQ:AMGN) Price Target Raised to $465.00Positive
- ipwatchdog.com · 1 outletRare Disease Treatment Patents after Amgen: Can Claims Cover Untested Genetic Mutations?Negative
- www.fool.com · 1 outletAmgen (AMGN) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 6 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amgen (NASDAQ:AMGN) Reaches New 1-Year High on Strong Earnings | www.themarketsdaily.com | 1 | Positive |
| Amgen (NASDAQ:AMGN) Stock Gets Price Target Increase from The Goldman Sachs Group | www.themarketsdaily.com | 1 | Positive |
| Amgen stock up after Q3 earnings beat | Pacific Coast Business Times | www.pacbiztimes.com | 1 | Positive |
| Amgen (NASDAQ:AMGN) Price Target Raised to $465.00 | www.themarketsdaily.com | 1 | Positive |
| Rare Disease Treatment Patents after Amgen: Can Claims Cover Untested Genetic Mutations? | ipwatchdog.com | 1 | Negative |
| Amgen (AMGN) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
4 headlines, average tone +25: 1 positive, 3 neutral and 0 negative. Showing all 4.
- markets.financialcontent.com · 1 outletFinancialContent - Amgen (NASDAQ:AMGN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectationsPositive
- www.morningstar.com · 1 outletAMGN - Amgen Inc Analysis | MorningstarNeutral
- www.themarketsdaily.com · 1 outletWhat Amgen (AMGN) Said on Its Q3 Earnings CallNeutral
- www.prnewswire.com · 1 outletAMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTSNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FinancialContent - Amgen (NASDAQ:AMGN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations | markets.financialcontent.com | 1 | Positive |
| AMGN - Amgen Inc Analysis | Morningstar | www.morningstar.com | 1 | Neutral |
| What Amgen (AMGN) Said on Its Q3 Earnings Call | www.themarketsdaily.com | 1 | Neutral |
| AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.fool.com · 2 outletsAmgen Just Gave Its Shareholders Great NewsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amgen Just Gave Its Shareholders Great News | www.fool.com | 2 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 29, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- baystreet.ca · 1 outletBaystreet.ca - Total Energy, ACT, Amgen at 52-Week Highs on NewsPositive
- www.prnewswire.com · 1 outletAMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTSNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Baystreet.ca - Total Energy, ACT, Amgen at 52-Week Highs on News | baystreet.ca | 1 | Positive |
| AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Amgen Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.